Here’s a link to a HealthXL webinar I joined a couple of days ago, with 2 US-based speakers reviewing the current state of play in the field of Digital Therapeutics. This covers process, criteria and suitability for adoption, the value or otherwise of efficacy vs effectiveness, regulatory clearances, prescription and reimbursement. Context is almost exclusively US market, but of interest to gauge the rate of travel for this emerging field of techs. A definition for DTx is given early on, physician adoption criteria at 31m, reimbursement from 46m.
PS unfortunately no slides, just a panel discussion format.
opengraphobject:[351561249812948 : https://zoom.us/recording/play/dc3w9Mfip8b-Q-D7hcI2NOHx5aeHoMNvun9PtnpmOgH9Rjw3Xe55rzXjZrj3dlJ3?continueMode=true : title=“Webinar: HealthXL - Digital Therapeutics - Zoom” : description=“”]